Member of the European Parliament, Maria Spiraki said in an appeal to the European Commission (EC) about the lack of medicines in Europe. According to her, this situation is due to interruptions in the production and supply of the necessary raw materials from China and India or their decrease.
“Increasing prices for previously cheap pharmaceuticals is being considered as a possible means of combating global shortages, provided that the main burden of such a measure does not fall on patients,” she added.
In the first half of January, it became known that the European Union plans to create a strategic stock of medicines and oblige manufacturers to guarantee their supply. The reason was that almost all 27 EU countries and the UK complained about the lack of essential medicines and devices: penicillin, paracetamol, inhalers, including children’s.
In her appeal, Spiraki also urged the EC to take action to address this issue.
At the same time, the medicine crisis, which the Turkish Ministry of Health has said will “be back to normal in 3-4 weeks,” continues to deepen. Pharmacists and doctors report that the problem of lack of medicines is aggravating, there is a shortage of antibiotics, painkillers and antipyretics. Despite the rise in the euro exchange rate demanded by the monopolies, the medicine crisis has not yet been resolved.